Granahan Investment Management’s iRadimed IRMD Stock Holding History

Granahan Investment Management’s Portfolio IRMD Stock Details IRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$472K	Buy	4,900 +8	+0.2%	+$800	0.02%	145
2025 Q4	$476K	Sell	4,892 -1,723	-26%	-$148K	0.02%	152
2025 Q3	$471K	Sell	6,615 -891	-12%	-$59.4K	0.02%	140
2025 Q2	$449K	Sell	7,506 -1,053	-12%	-$57.7K	0.02%	150
2025 Q1	$449K	Sell	8,559 -4,086	-32%	-$230K	0.02%	150
2024 Q4	$695K	Buy	12,645 +2,124	+20%	+$112K	0.03%	165
2024 Q3	$529K	Buy	+10,521	New	+$485K	0.02%	177

Other funds holding IRMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

NTCM

Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Granahan Investment Management's IRMD Position: Q1 2026 in Review

Granahan Investment Management increased its iRadimed (IRMD) stake by 0.16% in Q1 2026, buying an estimated $800 and bringing the position to 4,900 shares worth $472K. The position accounts for 0.02% of the portfolio, ranked #145.

Granahan Investment Management first reported a position in IRMD in Q3 2024 and has held it in 7 quarters since. The position peaked at $695K in Q4 2024. 228 funds tracked by Wall St. Rank hold IRMD as of Q1 2026.

Granahan Investment Management held 4,900 shares of iRadimed worth $472K as of Q1 2026.
Granahan Investment Management bought 8 iRadimed shares in Q1 2026, an estimated $800.
iRadimed made up 0.02% of Granahan Investment Management's portfolio in Q1 2026, its #145 holding.
Granahan Investment Management first reported a position in iRadimed in Q3 2024 and has held it in 7 quarters since.
Granahan Investment Management's iRadimed position peaked at $695K in Q4 2024.
228 funds tracked by Wall St. Rank held iRadimed as of Q1 2026.

Based on Granahan Investment Management's 13F filing for Q1 2026, filed 15 May 2026.